芪麦肺络平汤抑制线粒体复合物I介导的氧化应激改善博来霉素诱导的肺纤维化
本研究在博来霉素诱导的肺纤维化小鼠模型中,采用micro-CT成像和免疫组化验证芪麦肺络平汤(QM)的治疗效果,并通过4D-label-free蛋白质组学探讨机制。结果显示QM可抑制肺损伤、细胞外基质积累和TGF-β表达,其机制与抑制线粒体复合物I介导的氧化应激损伤有关;同时鉴定出甘草中的甘草苷和异甘草素可能为活性成分。
要点
- QM可抑制BLM诱导的肺损伤、ECM积累和TGF-β表达。
- QM通过抑制线粒体复合物I减少ROS、促进ATP生成。
- 甘草苷和异甘草素可能是QM抗PF的活性成分。
核心结论
- 芪麦肺络平汤可能通过抑制线粒体复合物I介导的线粒体氧化应激损伤来治疗肺纤维化。
研究设计与样本
- 采用博来霉素诱导的肺纤维化小鼠模型和细胞模型,结合micro-CT成像、免疫组化染色、4D-label-free蛋白质组学、UHPLC/IM-QTOF-MS分析。
主要发现
- QM治疗可抑制BLM诱导的肺损伤、细胞外基质积累和TGF-β表达。
- 蛋白质组学提示线粒体复合物I和II的部分亚基蛋白可能是QM抗肺纤维化的潜在靶点。
- QM可抑制BLM诱导的线粒体ROS含量,促进ATP生成,减少氧化应激损伤,该作用由抑制线粒体复合物I介导。
- 共鉴定出13个原型化合物和15个代谢物,甘草中的甘草苷和异甘草素可能是抗肺纤维化的活性化合物。
临床怎么用
- QM作为COVID-19康复期肺纤维化患者的康复方案组成部分,可能通过抑制线粒体复合物I介导的氧化应激发挥抗纤维化作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Qimai Feiluoping decoction (QM), a Traditional Chinese Medicine formula, has been included in rehabilitation program for functional disorders of discharged COVID-19 patients. QM has been proved to effectively improve the clinical symptoms and imaging signs of PF in COVID-19 convalescent patients. PURPOSE: This study to explore the pharmacological effect of QM against PF from the perspectives of imaging, pathological staining, and molecular mechanisms, and identify possible active components. METHODS: Micro-CT imaging and immunohistochemical staining were investigated to verify the therapeutic effect of QM in the bleomycin (BLM)-induced PF mouse model. The 4D-label-free proteomics analysis of lung tissues was then conducted to explore the novel mechanisms of QM against PF, which were further validated by a series of experiments. The possible components of QM in plasma and lung tissues were identified with UHPLC/IM-QTOF-MS analysis. RESULTS: The results from micro-CT imaging and pathological staining revealed that QM treatment can inhibit BLM-induced lung injury, extracellular matrix accumulation and TGF-β expression in the mouse model with PF. The 4D-label-free proteomics analysis demonstrated that the partial subunit proteins of mitochondrial complex I and complex II might be potential targets of QM against PF. Furthermore, QM treatment can inhibit BLM-induced mitochondrial ROS content to promote ATP production and decrease oxidative stress injury in the mouse and cell models of PF, which was mediated by the inhibition of mitochondrial complex I. Finally, a total of 13 protype compounds and 15 metabolites from QM in plasma and lung tissues were identified by UHPLC/IM-QTOF-MS, and liquiritin and isoliquiritigenin from Glycyrrhizae radix et rhizoma could be possible active compounds against PF. CONCLUSION: It concludes that QM treatment could treat PF by inhibiting mitochondrial complex I-mediated mitochondrial oxidated stress injury, which could offer new insights into the pharmacological mechanisms of QM in the clinical application of PF patients.
引用
- Ding L, Yang Y, Wang Z, et al. Qimai Feiluoping decoction inhibits mitochondrial complex I-mediated oxidative stress to ameliorate bleomycin-induced pulmonary fibrosis. Phytomedicine. 2023. PMID: 36805483. doi:10.1016/j.phymed.2023.154707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。